Icahn School Of Medicine At Mount Sinai - Jul 1, 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
10%+ Owner
Signature
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI By: /s/ Stephen Harvey, Name: Stephen Harvey, Chief Financial Officer
Stock symbol
RNLX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/3/2023, 08:55 AM
Previous filing
Feb 2, 2023
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNLX Ordinary Shares 9.96M Jul 1, 2023 Direct F1, F2
holding RNLX American Depositary Shares 2.33M Jul 1, 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNLX Stock Options (Right to Buy) Jul 1, 2023 Ordinary Shares 205K $1.54 Direct F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported herein are held directly by Icahn School of Medicine at Mount Sinai ("ISMMS").
F2 As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any.
F3 Each American Depositary Share of the Issuer represents two Ordinary Shares of the Issuer.
F4 948,750 American Depositary Shares are held directly by MSH and 1,382,489 American Depositary Shares are held directly by ISMMS.
F5 These stock options are fully vested.
F6 The exercise price was converted from GBP1.21, based on an exchange rate of USD1.27 to GBP1.00.